These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 31178490)
21. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis. Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968 [TBL] [Abstract][Full Text] [Related]
22. "Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan. Habu Y; Maeda K; Kusuda T; Yoshino T; Shio S; Yamazaki M; Hayakumo T; Hayashi K; Watanabe Y; Kawai K J Gastroenterol; 2005 Nov; 40(11):1029-35. PubMed ID: 16322946 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy. Seko T; Tachi T; Hatakeyama H; Noguchi Y; Teramachi H Int J Clin Pract; 2019 Jun; 73(6):e13349. PubMed ID: 30912226 [TBL] [Abstract][Full Text] [Related]
33. Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Maruyama M; Tanaka N; Kubota D; Miyajima M; Kimura T; Tokutake K; Imai R; Fujisawa T; Mori H; Matsuda Y; Wada S; Horiuchi A; Kiyosawa K Can J Gastroenterol Hepatol; 2017; 2017():4385161. PubMed ID: 28349044 [No Abstract] [Full Text] [Related]